The Latest Breaking News from FDA

FDA recalls more bagged, frozen shrimp over possible radioactive cesium contamination

The FDA is warning consumers not to eat certain frozen shrimp products sold at Walmart after other products from the same company tested positive for a radioactive substance.

LiveScience · Aug 19, 2025

Walmart recalls shrimp over possible radioactive contamination

FDA announced that certain Great Value raw frozen shrimp sold at Walmart could be potentially contaminated with Cesium-137, a radioactive isotope

The Independent UK · Aug 19, 2025

Thousands of pounds of cheese recalled over possible Listeria contamination

The source was determined to be ‘from environmental contamination that migrated to food-contact areas of the production process’

The Independent UK · Aug 19, 2025

Fabrinet, Adecoagro And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the SP 500 futures falling around 0.1% on Monday.

Benzinga · Aug 19, 2025

Why Is Soligenix Stock Soaring On Monday?

Soligenix, Inc. (NASDAQ:SNGX) stock is higher on Monday after the U.S. Food and Drug Administration granted orphan drug designation to dusquetide, the active ingredient in SGX945, for Behçet’s Disease.

Benzinga · Aug 18, 2025

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

The previous out-of-pocket price was nearly $1,000.

Fortune · Aug 18, 2025

Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows

Novo Nordisk A/S (NYSE:NVO) may have found a timely catalyst. From the lows of its 52-week trading range, the Danish drugmaker is showing signs that a bullish comeback might be on the horizon—driven by both regulatory approval momentum and technically solid market signals.

Benzinga · Aug 18, 2025

BioXcel Therapeutics (BTAI) Stock Is Surging Monday: What's Going On?

BioXcel Therapeutics Inc (NASDAQ:BTAI) shares are trading higher. The AI biopharmaceutical company on Monday announced positive meeting comments from the U.S. Food and Drug Administration (FDA).

Benzinga · Aug 18, 2025

Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years

On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s (NASDAQ:TNXP) Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults.

Benzinga · Aug 18, 2025

FDA's new expert panels are rife with financial conflicts and fringe views

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules and promoting fringe views about antidepressants and other products

The Independent UK · Aug 18, 2025